334 related articles for article (PubMed ID: 6311897)
21. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
23. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of antibody-dependent cellular cytotoxicity: the use of effector cells from chronic granulomatous disease patients as investigative probes.
Katz P; Simone CB; Henkart PA; Fauci AS
J Clin Invest; 1980 Jan; 65(1):55-63. PubMed ID: 6243141
[TBL] [Abstract][Full Text] [Related]
25. Staining of eosinophils with nitroblue tetrazolium in patients with chronic granulomatous disease.
Roberts RL; Ohno Y; Gallin JI
Pediatr Res; 1986 Apr; 20(4):378-80. PubMed ID: 2422626
[TBL] [Abstract][Full Text] [Related]
26. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
27. Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes: requirement for reactive metabolites of oxygen.
Seaman WE; Gindhart TD; Blackman MA; Dalal B; Talal N; Werb Z
J Clin Invest; 1982 Apr; 69(4):876-88. PubMed ID: 7076851
[TBL] [Abstract][Full Text] [Related]
28. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
29. Chronic granulomatous disease. Expression of the metabolic defect by in vitro culture of bone marrow progenitors.
Newburger PE; Kruskall MS; Rappeport JM; Robinson SH; Chovaniec ME; Cohen HJ
J Clin Invest; 1980 Sep; 66(3):599-602. PubMed ID: 6249853
[TBL] [Abstract][Full Text] [Related]
30. Cytochrome b deficiency in an autosomal form of chronic granulomatous disease. A third form of chronic granulomatous disease recognized by monocyte hybridization.
Weening RS; Corbeel L; de Boer M; Lutter R; van Zwieten R; Hamers MN; Roos D
J Clin Invest; 1985 Mar; 75(3):915-20. PubMed ID: 3980731
[TBL] [Abstract][Full Text] [Related]
31. Prenatal diagnosis of chronic granulomatous disease.
Matthay KK; Golbus MS; Wara DW; Mentzer WC
Am J Med Genet; 1984 Apr; 17(4):731-9. PubMed ID: 6720741
[TBL] [Abstract][Full Text] [Related]
32. Granule exocytosis in a cultured human natural killer cell-rich population induced by K562 target cells and by PMA/A23187.
Nagatake H; Watanabe N; Kobayashi Y
Cell Immunol; 1995 Apr; 161(2):295-8. PubMed ID: 7697741
[TBL] [Abstract][Full Text] [Related]
33. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
34. Free oxygen radicals are not detectable by chemiluminescence during human natural killer cell cytotoxicity.
Ramstedt U; Rossi P; Kullman C; Warren E; Palmblad J; Jondal M
Scand J Immunol; 1984 May; 19(5):457-64. PubMed ID: 6729407
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of suppression of natural killer cell activity in trauma patients.
Joshi P; Hauser CJ; Jones Q; Kennedy R; Thomae KR; Zhou X
Res Commun Mol Pathol Pharmacol; 1998 Sep; 101(3):241-8. PubMed ID: 9874282
[TBL] [Abstract][Full Text] [Related]
36. Optimization of conditions for in vitro production of radical oxygen species and expression of tissue factor by canine mononuclear cells and granulocytes for use in high-throughput assays.
Okano S; Hurley DJ; Bergh MS; Vandenplas ML; Budsberg SC; Moore JN
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):234-42. PubMed ID: 16750570
[TBL] [Abstract][Full Text] [Related]
37. Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system.
el-Hag A; Clark RA
J Immunol; 1987 Oct; 139(7):2406-13. PubMed ID: 2821114
[TBL] [Abstract][Full Text] [Related]
38. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.
Steinhauer EH; Doyle AT; Reed J; Kadish AS
J Immunol; 1982 Nov; 129(5):2255-9. PubMed ID: 7119445
[TBL] [Abstract][Full Text] [Related]
39. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
Farram E; Targan SR
J Immunol; 1983 Mar; 130(3):1252-6. PubMed ID: 6822733
[TBL] [Abstract][Full Text] [Related]
40. Nitroblue tetrazolium slide test. Use of the phorbol-myristate-acetate-stimulated NBT-reduction slide test for routine and prenatal detection of chronic granulomatous disease and diagnosis of heterozygous carriers.
Johansen KS
Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):349-54. PubMed ID: 6673503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
